北京科途医学科技有限公司
An Organoids Biotech Company
相关文献(临床研究相关)

类器官在肿瘤个性化医疗领域的论文和综述

1. Clevers H (2016) ModelingDevelopment and Disease with Organoids. Cell 165, 1586-1597.

2. Fong ELS, Toh TB, Yu H et al. (2017) 3D Culture as aClinically Relevant Model for Personalized Medicine. SLAS technology 22,245-253.

3. Broutier L, Mastrogiovanni G,Verstegen MM et al. (2017) Humanprimary liver cancer-derived organoid cultures for disease modeling and drugscreening. Nature medicine.

4. Francies HE, Garnett MJ (2015)What role could organoids play in the personalization of cancer treatment? Pharmacogenomics 16, 1523-1526.

5. Yamamoto Y, Gotoh S, Korogi Y et al. (2017) Long-term expansion ofalveolar stem cells derived from human iPS cells in organoids. Nature methods 14, 1097-1106.

6. Walsh AJ, Cook RS, Skala MC(2017) Functional Optical Imaging of Primary Human Tumor Organoids: Developmentof a Personalized Drug Screen. Journal ofnuclear medicine : official publication, Society of Nuclear Medicine 58, 1367-1372.

7. Majumder B, Baraneedharan U,Thiyagarajan S et al. (2015)Predicting clinical response to anticancer drugs using an ex vivo platform thatcaptures tumour heterogeneity. Naturecommunications 6, 6169.

8. Picco G, Garnett MJ (2017) ARoad Map for Precision Cancer Medicine Using Personalized Models. Cancer discovery 7, 456-458.

9. Bartucci M, Ferrari AC, Kim IY et al.(2016) Personalized Medicine Approaches in Prostate Cancer Employing PatientDerived 3D Organoids and Humanized Mice. Frontiersin cell and developmental biology 4,64.


类器官标本库

10. van de Wetering M, FranciesHE, Francis JM et al. (2015)Prospective derivation of a living organoid biobank of colorectal cancerpatients. Cell 161, 933-945.

11. Clevers H, Bender E (2015) Q&A: Hans Clevers. Banking on organoids. Nature 521, S15.


类器官作为疾病模型和肿瘤基础研究领域的论

12. Weeber F, van de Wetering M,Hoogstraat M et al. (2015) Preservedgenetic diversity in organoids cultured from biopsies of human colorectalcancer metastases. Proceedings of theNational Academy of Sciences of the United States of America 112, 13308-13311.

13. Dedhia PH, Bertaux-Skeirik N,Zavros Y et al. (2016) OrganoidModels of Human Gastrointestinal Development and Disease. Gastroenterology 150,1098-1112.

14. Nolan E, Vaillant F, Branstetter D et al.(2016) RANK ligand as a potential target for breast cancer

prevention in BRCA1-mutationcarriers. Nature medicine 22, 933-939.

15. Boj SF, Hwang CI, Baker LA et al. (2016) Model organoids providenew research opportunities for ductal pancreatic cancer. Molecular & cellular oncology 3, e1014757.

16. Wang S, Gao D, Chen Y (2017)The potential of organoids in urological cancer research. Nature reviews Urology 14,401-414.

17. Baker LA, Tiriac H, Clevers H et al. (2016) Modeling pancreaticcancer with organoids. Trends in cancer 2, 176-190.

18. Guye P, Ebrahimkhani MR,Kipniss N et al. (2016) Geneticallyengineering self-organization of human pluripotent stem cells into a liverbud-like tissue using Gata6. Naturecommunications 7, 10243.

19. Quadrato G, Nguyen T, MacoskoEZ et al. (2017) Cell diversity andnetwork dynamics in photosensitive human brain organoids. Nature 545, 48-53.

20. McCracken KW, Cata EM,Crawford CM et al. (2014) Modellinghuman development and disease in pluripotent stem-cell-derived gastricorganoids. Nature 516, 400-404.

21. Takasato M, Er PX, Chiu HS et al. (2015) Kidney organoids fromhuman iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564-568.

22. Qian X, Nguyen HN, Song MM et al. (2016) Brain-Region-SpecificOrganoids Using Mini-bioreactors for Modeling ZIKV Exposure. Cell 165, 1238-1254.

23. Drost J, van Boxtel R, Blokzijl F et al.(2017) Use of CRISPR-modified human stem cell organoids to study the origin ofmutational signatures in cancer. Science 358, 234-238.